上海凯宝：更换持续督导保荐代表人

Core Viewpoint - Shanghai Kaibao Pharmaceutical Co., Ltd. has announced a change in its continuous supervision representative for its initial public offering (IPO) on the ChiNext board, with a new representative appointed to ensure orderly supervision [1]. Group 1 - The company received a notification from its sponsor, Dongwu Securities, regarding the replacement of the continuous supervision representative [1]. - The original representative, Ms. Liu Ting, will no longer perform the supervisory duties due to a job change [1]. - Ms. Zhai Yue has been appointed to take over the continuous supervision responsibilities [1].